Close

Biocept (BIOC) Reports $2.5 Million Registered Direct Offering of Common Stock, Warrants Priced at Market

September 21, 2018 7:03 AM EDT Send to a Friend
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login